Delivery Order SPE2DR25D3504-SPE2DR26F7CF9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,755.24 to Amerisourcebergen Drug Corp for Vaxelis vaccine syringes in 0.5ML configuration, with performance completion expected by January 14, 2026. This is a firm fixed-price, non-set-aside contract performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated...
- The Defense Logistics Agency awarded a delivery order valued at $1,726.59 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on December 23, 2025, with an ultimate completion date of December 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this transaction. The award represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,906.36 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5ml) on December 10, 2025, with an ultimate completion date of December 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a small-value transaction under AmerisourceBergen's existing federal contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,178.77 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on January 6, 2026, with an ultimate completion date of January 7, 2026. This is a firm fixed-price delivery order with no set-aside designation, performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor and critical federal medical vendor that...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,124.72 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5 mL) on November 7, 2025, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $3,453.18 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on December 23, 2025, with an ultimate completion date of December 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $24,239.08 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on September 14, 2025, with completion targeted for September 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract is being...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) with a ceiling value of $7,584.73. The delivery order, issued on December 19, 2025, is scheduled for completion by December 22, 2025, and represents a non-set-aside competitive award. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this procurement, supporting the agency's medical supply chain...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) valued at $1,230.36 under a firm fixed-price contract structure. The award, issued on January 5, 2026, is scheduled for completion by January 6, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order utilizing firm fixed-price terms, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $6,406.74 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5ML) on November 13, 2025, with an ultimate completion date of November 14, 2025. This firm fixed-price contract represents a non-set-aside competitive award for medical supply procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement...
- SPE2DR25D3504Indefinite Delivery Contract
- SPE2DR25D3504-SPE2DR26F7CF9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,230.36 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, non-set-aside contract represents a firm fixed-price purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and extending through December 2026. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving critical federal medical procurement needs across the Defense Logistics Agency and other government healthcare systems. Through its comprehensive IDC vehicle, the company supplies an extensive portfolio of pharmaceutical products and medical commodities—including specialty medications, vaccines, syringes, and related medical supplies—to support military healthcare programs globally. This delivery order for vaccine syringes aligns with the company's established role as a key vendor for federal medical supply chain operations supporting military treatment facilities and other Department of Defense healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/11/26 |